All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Chapter 5: Infections
Toggle Parent Pages
Print this page
Principles of antibacterial treatment
Coronavirus disease (COVID-19)
Eye infections
Gastro-intestinal tract infections
Genital tract infections
Meningitis
Oral and dental infections
Respiratory tract infections
Skin and soft tissue infections
Urinary tract infections (UTI)
5.1 Antibacterial drugs
5.2 Antifungal drugs
5.3 Antiviral drugs
5.4 Antiprotozoal drugs
5.5 Anthelmintics
Contact us about this page
Management of traveller’s diarrhoea
First Line
Second Line
Specialist
Hospital Only
Only consider standby antibiotics for remote areas or people at high-risk of severe illness with travellers' diarrhoea.
If standby treatment appropriate give:
- Ciprofloxacin 500 mg twice a day for 3 days (private prescription only, not on FP10)
Notes
- MHRA Drug Safety Update (November 2018): Systemic and inhaled fluoroquinolones: small increased risk of aortic aneurysm and dissection; advice for prescribing in high-risk patients..
- MHRA Drug Safety Update (March 2019): Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects.
- MHRA Drug Safety Update (December 2020): Systemic and inhaled fluoroquinolones: small risk of heart valve regurgitation; consider other therapeutic options first in patients at risk.
Refer to 5.1.12 Quinolones for further details.
